Vimarsana
Biggest News Aggregation in the World

Page 21 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Umer Raffat Today - Breaking & Trending Today

Manufacturing issues spur FDA to deny approval of Lilly colitis drug - Vimarsana News

Manufacturing issues spur FDA to deny approval of Lilly colitis drug

BioPharma

Biogen Faces Robust Questions On An Annual Value Of $ 56,000 For A Newly Accredited Alzheimer's Drug • MV TELEGRAPH - Vimarsana News

Biogen Faces Robust Questions On An Annual Value Of $ 56,000 For A Newly Accredited Alzheimer's Drug • MV TELEGRAPH

A person skates past Biogen Inc. headquarters in Cambridge, Massachusetts on Monday, June 7, 2021.

Comment: How the Pfizer-Seagen deal can help both companies - Vimarsana News

Comment: How the Pfizer-Seagen deal can help both companies

Despite the $43 billion price tag, Pfizer can count on durable income while Seagen gets a wide pipeline.

Pfizer's Covid cash spend includes acquiring Seagen to build Cancer drugs - Vimarsana News

Pfizer's Covid cash spend includes acquiring Seagen to build Cancer drugs

The deal could put Pfizer into a leadership position in oncology. But Pfizer still has a lot of work to do to convince investors that its huge bet on Seagen is sound.

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2022 Earnings Call Transcript - Vimarsana News

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2022 Earnings Call Transcript

Operator: Good afternoon. My name is Gary, and I will be your conference operator today.